Remove 2004 Remove Clinical Trials Remove Patients Remove Sativa
article thumbnail

Cannabis for IBS: Treating Irritable Bowel Syndrome with Medical Marijuana

Greencamp

The stress response in IBS patients causes abnormalities in the functioning of the sympathetic nervous system (one of the divisions of the autonomic or “subconscious” nervous system) and to the HPA axis. During a three-month period, 13 patients with long-standing IBS were given cannabis. How to choose the best strain for IBS?

article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

The fact that migraine is now ranked as the second leading cause of years lived with disability illustrates the magnitude of the negative impact of the disease to patients and their ability to function normally. A 2019 retrospective review of 316 patients found that medical cannabis improved the experience of 88.3%

Terpenes 132
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94
article thumbnail

Cannabis Goes To Davos !

Cannabis Law Report

The burgeoning cannabis industry is poised to revolutionize patient care and the leisure industry and these changes are creating new international ecosystems that will have massive impact, from local farm workers to the world’s largest corporations. CNBX) is a U.S Visit [link]. About Plena.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.